Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,326,864
+$99,780 QoQ
Shares Held
216,808
+22.1% QoQ
Ownership
0.359%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. VNDA ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,326,864 | 216,808 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,227,084 | 177,581 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $991,323 | 112,395 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $147,165 | 29,492 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $324,259 | 68,699 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $678,043 | 147,722 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $915,943 | 191,220 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,134,914 | 241,986 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,378,549 | 243,991 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,003,830 | 244,241 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,262,721 | 299,223 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,722,246 | 630,150 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,044,419 | 1,068,956 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,729,194 | 991,045 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $6,223,495 | 842,151 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,013,749 | 912,323 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,528,432 | 782,425 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,033,906 | 798,754 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,913,118 | 759,281 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,455,146 | 376,613 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ALXN | — | 400,428 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $7,919,916 | 368,197 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ALXN | — | 415,761 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $5,051,330 | 336,307 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 ALXN | — | 2,350,743 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $5,168,040 | 393,306 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 ALXN | — | 5,100,886 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 | $4,443,483 | 459,988 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 ALXN | — | 6,036,636 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $4,203,261 | 367,418 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 ALXN | — | 6,282,877 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $3,854,976 | 372,102 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||